Aldeyra The (ALDX)
$0.92-3.16%Close
SELLCRISIS · day 12
Key stats
Short interest · FINRA settlement 2026-09-30
52-week IV0.1%–493.8%
- Market cap
- $55M
- Beta
- 1.20
- P/E (TTM)
- -2.37
- IV-%ile
- 41
- IV ATM
- 145.6%
- Short % float
- 6.59%
- Days to cover
- 3.0
- SI change
- -3.7%
- 1W
- -21.37%
- 1M
- -36.99%
- vs SPY 1W
- -22.53%
- vs SPY 1M
- -39.98%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on ALDX?
- LOPJLB’s latest quantitative signal on Aldeyra The (ALDX) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is ALDX in?
- Aldeyra The (ALDX) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Aldeyra The (ALDX) do?
- Aldeyra Therapeutics, Inc., a biotechnology company, discovers and develops therapies designed to treat immune-mediated diseases. Its lead product candidate is reproxalap, a reactive aldehyde species (RASP) modulator, which is in Phase III clinical trial for the treatment of dry eye disease and allergic conjunctivitis; and ADX-2191, a dihydrofolate reductase inhibitor for the treatment of prima…